• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Lab Hematol . Clinical and hematological characteristics of 88 patients with COVID-19

tetano

Editor, Senior Moderator
Int J Lab Hematol


. 2020 Jul 23;10.1111/ijlh.13291.
doi: 10.1111/ijlh.13291. Online ahead of print.
Clinical and hematological characteristics of 88 patients with COVID-19


Hongmei Zhang[SUP] 1 [/SUP], Xiaocui Cao[SUP] 1 [/SUP], Man Kong[SUP] 1 [/SUP], Xiaoli Mao[SUP] 1 [/SUP], Lifeng Huang[SUP] 1 [/SUP], Panwen He[SUP] 1 [/SUP], Shiyao Pan[SUP] 2 [/SUP], Jin Li[SUP] 2 [/SUP], Zhongxin Lu[SUP] 1 [/SUP]



Affiliations

Abstract

Introduction: To retrospectively analyze epidemiological, clinical and hematological characteristics of COVID-19 patients.
Methods: The demographic, symptoms, and physiological parameters of 88 patients were collected and analyzed. The performance of complete blood count (CBC) indexes for monitoring and predicting the severity of COVID-19 in patients was evaluated by analyzing and comparing CBC results among different COVID-19 patient groups.
Results: White blood cells (WBCs), the neutrophil percentage (Neu%), absolute neutrophil count (Neu#), and neutrophil-to-lymphocyte ratio (NLR) were significantly higher in the critical group than in the other three groups (P < .05), while the lymphocyte percentage (Lym%), monocyte percentage (Mon%), lymphocyte count (Lym#), and lymphocyte-to-monocyte ratio (LMR) were significantly lower in the critical group than in the other three groups (P < .05). WBCs, the Neu%, Neu#, NLR, and neutrophil-to-monocyte ratio (NMR) were significantly higher in the severe group than in the mild and moderate groups (P < .05), while the Lym% was significantly lower in the severe group than in the mild and moderate groups (P < .05). The Mon%, Lym#, and LMR were significantly lower in the severe group than in the moderate group (P < .05). Using receiver operating characteristic (ROC) curve analysis to differentiate severe and nonsevere patients, the areas under the curve (AUCs) for the NLR, Neu%, and Lym% were 0.733, 0.732, and 0.730, respectively. When differentiating critical patients from noncritical patients, the AUCs for the NLR, Neu%, and Lym% were 0.832, 0.831, and 0.831.
Conclusions: The NLR is valuable for differentiating and predicting patients who will become critical within 4 weeks after the onset of COVID-19.

Keywords: BC‐6800plus; COVID‐19; clinical characteristics; hematology; neutrophil‐to‐lymphocyte ratio; novel coronavirus (SARS‐Cov‐2).
 
Back
Top Bottom